DOX-TPP

biotech grade

Reagent Code: #97022

blur_circular Chemical Specifications

inventory_2 Storage & Handling
Storage 2-8℃

description Product Description

DOX-TPP is primarily utilized in the field of targeted drug delivery, especially in cancer therapy. It combines the chemotherapeutic agent doxorubicin (DOX) with a mitochondrial-targeting ligand, triphenylphosphonium (TPP), to enhance the precision of drug delivery. This conjugate is designed to specifically target cancer cell mitochondria, where it can induce apoptosis more effectively. By concentrating the drug within the mitochondria, DOX-TPP minimizes damage to healthy cells, reducing side effects commonly associated with traditional chemotherapy. Its application is particularly promising in treating resistant cancers, as it overcomes some of the limitations of conventional treatments by improving cellular uptake and therapeutic efficacy.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance Solid
Substitution 95-100%
1H NMR Identical to the Structure
Infrared Spectrum Conforms to Structure
Foreign Material None

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿34,800.00
inventory 5mg
10-20 days ฿10,500.00
inventory 25mg
10-20 days ฿20,580.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB